CTN

Studies associated with:

Clinical Trials Network

Division Study Number Title Investigator(s) Release Date
CTN NIDA-CTN-0059 The TAPS Tool: Screen and Brief Assessment Tool Validation Study Robert P Schwartz, M.D., Li-Tzy Wu, Psy.D., Jennifer McNeely, M.D.
CTN NIDA-CTN-0056 Testing and Linkage to HIV Care in China: A Cluster Randomized Trial Zunyou Wu, MD, PhD
CTN NIDA-CTN-0017 HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings Robert Booth, Ph.D.
CTN NIDA-CTN-0047 Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) Michael P. Bogenschutz, M.D., Dennis Donovan, Ph.D.
CTN NIDA-CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment Donald A. Calsyn, Ph.D.
CTN NIDA-CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC) Theresa Winhusen, Ph.D.
CTN NIDA-CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB) Walter Ling, M.D.
CTN NIDA-CTN-0046 Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes Theresa Winhusen, Ph.D., Eugene Somoza, M.D.
CTN NIDA-CTN-0044 Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders Edward V. Nunes, M.D.
CTN NIDA-CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Madhukar H. Trivedi, M.D.
CTN NIDA-CTN-AWARE Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. – an Adaptation of CTN-0032 Lisa Metsch, Ph.D., Grant Colfax, M.D.
CTN NIDA-CTN-0032 HIV Rapid Testing and Counseling in Drug Abuse Treatment Programs in the U.S. Lisa Metsch, Ph.D.
CTN NIDA-CTN-0031A An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association With Treatment Outcomes in Methamphetamine and Cocaine Abusers Theresa Winhusen, Ph.D., Eugene Somoza, M.D.
CTN NIDA-CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement Dennis Donovan, Ph.D., Dennis Daley, Ph.D.
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence) Roger Weiss, M.D., Jennifer Sharpe Potter, Ph.D.
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence Walter Ling, M.D., Roger Weiss, M.D.
CTN NIDA-CTN-0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD Theresa Winhusen, Ph.D., Eugene Somoza, M.D.
CTN NIDA-CTN-0028 Osmotic-Release Methylphenidate (OROS-MPH) for ADHD in Adolescents with Substance Use Disorders Paula Riggs, M.D.
CTN NIDA-CTN-0027 Starting Treatment with Agonist Replacement Therapies (START) Walter Ling, M.D.
CTN NIDA-CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse Kathleen Carroll, Ph.D., José Szapocznik, Ph.D.
CTN NIDA-CTN-0020 Job Seekers Training for Patients with Drug Dependence Dace Svikis, Ph.D.
CTN NIDA-CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment Susan Tross, Ph.D.
CTN NIDA-CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Robert Forman, Ph.D.
CTN NIDA-CTN-0015 Women's Treatment for Trauma and Substance Use Disorders Denise Hien, Ph.D.
CTN NIDA-CTN-0014 Brief Strategic Family Therapy (BSFT) For Adolescent Drug Abusers José Szapocznik, Ph.D.
CTN NIDA-CTN-0013 Motivational Enhancement Therapy (MET) to Improve Treatment Utilization and Outcome in Pregnant Substance Users Theresa Winhusen, Ph.D.
CTN NIDA-CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs Lawrence Brown, Jr., M.D., M.P.H.
CTN NIDA-CTN-0011 A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities Robert L. Hubbard, Ph.D., M.B.A.
CTN NIDA-CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults George Woody, M.D.
CTN NIDA-CTN-0009 Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs Malcolm Reid, Ph.D.
CTN NIDA-CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation Dennis McCarty, Ph.D.
CTN NIDA-CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics Maxine Stitzer, Ph.D.
CTN NIDA-CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics Maxine Stitzer, Ph.D.
CTN NIDA-CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse Kathleen Carroll, Ph.D.
CTN NIDA-CTN-0004 MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse Kathleen Carroll, Ph.D.
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules Walter Ling, M.D.
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification Walter Ling, M.D.
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification Walter Ling, M.D.